Mutations in the amyloid precursor protein (APP) (>50 different mutations), presenilin 1 (PSEN1 > 300 mutations), and presenilin-2 (PSEN2 > 40 mutations) genes are present in a number of AD cases (5–10%), and induce brain amyloidopathy. This evidence concerns the gene APP and Alzheimer disease.